688626 翔宇医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.1644.98611.3056.49715.075
总资产报酬率 ROA (%)1.4193.7309.1595.51412.762
投入资产回报率 ROIC (%)1.6404.31210.4686.11514.174

边际利润分析
销售毛利率 (%)67.19067.41968.62166.27468.230
营业利润率 (%)8.48714.59432.84527.72942.801
息税前利润/营业总收入 (%)6.40111.23328.76121.76937.965
净利润/营业总收入 (%)7.80413.83330.65425.23838.117

收益指标分析
经营活动净收益/利润总额(%)37.82781.15288.16556.02673.954
价值变动净收益/利润总额(%)13.8471.3063.80810.2655.444
营业外收支净额/利润总额(%)-2.872-1.192-0.245-1.858-0.601

偿债能力分析
流动比率 (X)1.2571.5543.2094.7429.462
速动比率 (X)0.9871.2302.5614.1098.583
资产负债率 (%)37.63429.82018.69918.08310.857
带息债务/全部投入资本 (%)23.21214.1091.6584.5370.675
股东权益/带息债务 (%)308.559570.0815,627.7522,023.87014,295.461
股东权益/负债合计 (%)164.581233.500431.387450.141816.587
利息保障倍数 (X)-3.462-3.522-7.185-3.992-8.289

营运能力分析
应收账款周转天数 (天)34.79228.73420.64026.80124.050
存货周转天数 (天)397.292356.335357.501417.574313.367